Clinical Trials
3 trialsNCT04214626 2025-11-19
R-CHOP Combined With Lenalidomide in the First-line Treatment for Patients With Diffuse Large B Cell Lymphoma
Henan Cancer Hospital
Phase 2 Completed
NCT04065789 2022-01-27
KyDaR
Tel-Aviv Sourasky Medical Center
Phase 2 Completed
NCT04326296 2020-05-15
The Safety and Tolerability of PD-L1 Monoclonal Antibody Plus Lenalidomide in The Treatment of Colorectal Cancer
Henan Cancer Hospital
Phase 1 Unknown